Investors
High-Level Commercial Due Diligence in Digital Pathology
Due Diligence
Due Diligence
Objective
An early-stage venture firm requested a high-level commercial due diligence of a potential investment
Our Approach
Secondary Research
- Assessed the competitive landscape and clinical workflows in specific indications to understand how the company fits in
Primary Research
- Conducted 13 interviews with experts from biopharma, clinical settings, and industry to assess the company's value proposition
Outcome
DeciBio presented a deliverable detailing the digital pathology landscape, the company's niche in the space, and potential go-to-market plans and considerations.
Quantitative Analysis
- Company revenue estimation using comparable competitors as benchmarks
Qualitative Analysis
- Potential clinical pricing / commercialization models
- Timeline to clinic
- Clinical go-to-market considerations by geography and stakeholder type
4 weeks
U.S. and Europe
Related Client Results
The incumbent's customers were leaving. The question was where to catch them.
Product Strategy
Go-to-Market Strategy
Synthetic mRNA Production Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Market Landscaping and Sizing
IVDR Opportunity Assessment
Voice-of-Customer Research
